Chloroquine for the 2019 novel coronavirus SARS-CoV-2

doi:10.1016/j.ijantimicag.2020.105923

Editorial

. 2020 Mar;55(3):105923.

doi: 10.1016/j.ijantimicag.2020.105923. Epub 2020 Feb 15.

Chloroquine for the 2019 novel coronavirus SARS-CoV-2

Philippe Colson¹, Jean-Marc Rolain¹, Didier Raoult²

Affiliations

¹ Aix-Marseille Université, Institut de Recherche pour le Développement (IRD), Assistance Publique-Hôpitaux de Marseille (AP-HM), MEPHI, 27 boulevard Jean Moulin, 13005 Marseille, France; IHU Méditerranée Infection, 19-21 boulevard Jean Moulin, 13005 Marseille, France.
² Aix-Marseille Université, Institut de Recherche pour le Développement (IRD), Assistance Publique-Hôpitaux de Marseille (AP-HM), MEPHI, 27 boulevard Jean Moulin, 13005 Marseille, France; IHU Méditerranée Infection, 19-21 boulevard Jean Moulin, 13005 Marseille, France. Electronic address: didier.raoult@gmail.com.

PMID: 32070753
PMCID: PMC7134866
DOI: 10.1016/j.ijantimicag.2020.105923

Editorial

Chloroquine for the 2019 novel coronavirus SARS-CoV-2

Philippe Colson et al. Int J Antimicrob Agents. 2020 Mar.

. 2020 Mar;55(3):105923.

doi: 10.1016/j.ijantimicag.2020.105923. Epub 2020 Feb 15.

Authors

Philippe Colson¹, Jean-Marc Rolain¹, Didier Raoult²

Affiliations

¹ Aix-Marseille Université, Institut de Recherche pour le Développement (IRD), Assistance Publique-Hôpitaux de Marseille (AP-HM), MEPHI, 27 boulevard Jean Moulin, 13005 Marseille, France; IHU Méditerranée Infection, 19-21 boulevard Jean Moulin, 13005 Marseille, France.
² Aix-Marseille Université, Institut de Recherche pour le Développement (IRD), Assistance Publique-Hôpitaux de Marseille (AP-HM), MEPHI, 27 boulevard Jean Moulin, 13005 Marseille, France; IHU Méditerranée Infection, 19-21 boulevard Jean Moulin, 13005 Marseille, France. Electronic address: didier.raoult@gmail.com.

PMID: 32070753
PMCID: PMC7134866
DOI: 10.1016/j.ijantimicag.2020.105923

No abstract available

PubMed Disclaimer

Comment on

A pneumonia outbreak associated with a new coronavirus of probable bat origin.
Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, Si HR, Zhu Y, Li B, Huang CL, Chen HD, Chen J, Luo Y, Guo H, Jiang RD, Liu MQ, Chen Y, Shen XR, Wang X, Zheng XS, Zhao K, Chen QJ, Deng F, Liu LL, Yan B, Zhan FX, Wang YY, Xiao GF, Shi ZL. Zhou P, et al. Nature. 2020 Mar;579(7798):270-273. doi: 10.1038/s41586-020-2012-7. Epub 2020 Feb 3. Nature. 2020. PMID: 32015507 Free PMC article.

Cited by

Preclinical and Clinical Investigations of Potential Drugs and Vaccines for COVID-19 Therapy: A Comprehensive Review With Recent Update.
Mia ME, Howlader M, Akter F, Hossain MM. Mia ME, et al. Clin Pathol. 2024 Jul 26;17:2632010X241263054. doi: 10.1177/2632010X241263054. eCollection 2024 Jan-Dec. Clin Pathol. 2024. PMID: 39070952 Free PMC article. Review.
Potential Therapeutic Options for COVID-19.
Zheng X, Li L. Zheng X, et al. Infect Microbes Dis. 2020 Jul 16;2(3):89-95. doi: 10.1097/IM9.0000000000000033. eCollection 2020 Sep. Infect Microbes Dis. 2020. PMID: 38630098 Free PMC article. Review.
A narrative review on adverse drug reactions of COVID-19 treatments on the kidney.
Jahanshahi F, Jazayeri SB, Eraghi MM, Reis LO, Hamidikia M, Amiri S, Aghamir SMK. Jahanshahi F, et al. Open Med (Wars). 2024 Mar 15;19(1):20230867. doi: 10.1515/med-2023-0867. eCollection 2024. Open Med (Wars). 2024. PMID: 38584847 Free PMC article. Review.
Global prevalence of persistent neuromuscular symptoms and the possible pathomechanisms in COVID-19 recovered individuals: A systematic review and meta-analysis.
Fajar JK, Ilmawan M, Mamada SS, Mutiawati E, Husnah M, Yusuf H, Nainu F, Sirinam S, Keam S, Ophinni Y, Rosiello F, Fahriani M, Rosa SGV. Fajar JK, et al. Narra J. 2021 Dec;1(3):e48. doi: 10.52225/narra.v1i3.48. Epub 2021 Dec 1. Narra J. 2021. PMID: 38450213 Free PMC article.
Syringa reticulata potently inhibits the activity of SARS-CoV-2 3CL protease.
Hao Z, Liu Y, Guan W, Pan J, Li M, Wu J, Liu Y, Kuang H, Yang B. Hao Z, et al. Biochem Biophys Rep. 2023 Dec 26;37:101626. doi: 10.1016/j.bbrep.2023.101626. eCollection 2024 Mar. Biochem Biophys Rep. 2023. PMID: 38371528 Free PMC article.

See all "Cited by" articles

References

1. Mullard A. Drug repurposing programmes get lift off. Nat Rev Drug Discov. 2012;11:505–506. doi: 10.1038/nrd3776. - DOI - PubMed
1. Zhou P., Yang X.L., Wang X.G., Hu B., Zhang L., Zhang W. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020 Feb 3 doi: 10.1038/s41586-020-2012-7. [Epub ahead of print] - DOI - PMC - PubMed
1. Savarino A., Di Trani L., Donatelli I., Cauda R., Cassone A. New insights into the antiviral effects of chloroquine. Lancet Infect Dis. 2006;6:67–69. doi: 10.1016/S1473-3099(06)70361-9. - DOI - PMC - PubMed
1. Rolain J.M., Colson P., Raoult D. Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century. Int J Antimicrob Agents. 2007;30:297–308. doi: 10.1016/j.ijantimicag.2007.05.015. - DOI - PMC - PubMed
1. Vincent M.J., Bergeron E., Benjannet S., Erickson B.R., Rollin P.E., Ksiazek T.G. Chloroquine is a potent inhibitor of SARS coronavirus infection and spread. Virol J. 2005;2:69. doi: 10.1186/1743-422X-2-69. - DOI - PMC - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- The Lens - Patent Citations
Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal

[1] Mullard A. Drug repurposing programmes get lift off. Nat Rev Drug Discov. 2012;11:505–506. doi: 10.1038/nrd3776. - DOI - PubMed

[2] Mullard A. Drug repurposing programmes get lift off. Nat Rev Drug Discov. 2012;11:505–506. doi: 10.1038/nrd3776. - DOI - PubMed

[3] Zhou P., Yang X.L., Wang X.G., Hu B., Zhang L., Zhang W. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020 Feb 3 doi: 10.1038/s41586-020-2012-7. [Epub ahead of print] - DOI - PMC - PubMed

[4] Zhou P., Yang X.L., Wang X.G., Hu B., Zhang L., Zhang W. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020 Feb 3 doi: 10.1038/s41586-020-2012-7. [Epub ahead of print] - DOI - PMC - PubMed

[5] Savarino A., Di Trani L., Donatelli I., Cauda R., Cassone A. New insights into the antiviral effects of chloroquine. Lancet Infect Dis. 2006;6:67–69. doi: 10.1016/S1473-3099(06)70361-9. - DOI - PMC - PubMed

[6] Savarino A., Di Trani L., Donatelli I., Cauda R., Cassone A. New insights into the antiviral effects of chloroquine. Lancet Infect Dis. 2006;6:67–69. doi: 10.1016/S1473-3099(06)70361-9. - DOI - PMC - PubMed

[7] Rolain J.M., Colson P., Raoult D. Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century. Int J Antimicrob Agents. 2007;30:297–308. doi: 10.1016/j.ijantimicag.2007.05.015. - DOI - PMC - PubMed

[8] Rolain J.M., Colson P., Raoult D. Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century. Int J Antimicrob Agents. 2007;30:297–308. doi: 10.1016/j.ijantimicag.2007.05.015. - DOI - PMC - PubMed

[9] Vincent M.J., Bergeron E., Benjannet S., Erickson B.R., Rollin P.E., Ksiazek T.G. Chloroquine is a potent inhibitor of SARS coronavirus infection and spread. Virol J. 2005;2:69. doi: 10.1186/1743-422X-2-69. - DOI - PMC - PubMed

[10] Vincent M.J., Bergeron E., Benjannet S., Erickson B.R., Rollin P.E., Ksiazek T.G. Chloroquine is a potent inhibitor of SARS coronavirus infection and spread. Virol J. 2005;2:69. doi: 10.1186/1743-422X-2-69. - DOI - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Chloroquine for the 2019 novel coronavirus SARS-CoV-2

Affiliations

Chloroquine for the 2019 novel coronavirus SARS-CoV-2

Authors

Affiliations

Comment on

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Miscellaneous

Comment on

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Related information

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Miscellaneous